Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-126 |
Sentence |
denotes |
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect. |
T2 |
127-138 |
Sentence |
denotes |
BACKGROUND: |
T3 |
139-273 |
Sentence |
denotes |
Antibody testing has recently emerged as an option to assist with determining exposure to SARS-CoV-2, the causative agent of COVID-19. |
T4 |
274-426 |
Sentence |
denotes |
Elucidation of the kinetics and duration of the humoral response is important for clinical management and interpreting results from serological surveys. |
T5 |
427-438 |
Sentence |
denotes |
OBJECTIVES: |
T6 |
439-618 |
Sentence |
denotes |
Here we evaluated the clinical performance of Abbott SARS-CoV-2 IgM and IgG assays, as well as the longitudinal dynamics of the antibody response in symptomatic COVID-19 patients. |
T7 |
619-644 |
Sentence |
denotes |
STUDY DESIGN AND RESULTS: |
T8 |
645-749 |
Sentence |
denotes |
The diagnostic specificity was 100 % for IgM and 99.67 % for IgG using 300 pre-COVID-19 serum specimens. |
T9 |
750-1034 |
Sentence |
denotes |
Using 1349 sequential serum samples collected up to 168 days post symptom onset from 427 PCR-confirmed individuals, clinical test sensitivity of the SARS-CoV-2 IgM assay was 24.6 % at ≤7 days, 75.3 % at 8-14 days, 95.0 % at 15-21 days, and 96.0 % at 4-5 weeks (peak test sensitivity). |
T10 |
1035-1098 |
Sentence |
denotes |
The median duration of time for IgM seroconversion was 10 days. |
T11 |
1099-1212 |
Sentence |
denotes |
IgM levels declined steadily 4-5 weeks after symptom onset, and the positive rate dropped to 30.8 % at >3 months. |
T12 |
1213-1402 |
Sentence |
denotes |
The diagnostic sensitivity for the SARS-CoV-2 IgG assay post symptom onset was 23.2 % at ≤7 days, 69.5 % at 8-14 days, 93.6 % at 15-21 days, and 99.6 % at 4-5 weeks (peak test sensitivity). |
T13 |
1403-1468 |
Sentence |
denotes |
The median duration of time for IgG seroconversion was 11.5 days. |
T14 |
1469-1601 |
Sentence |
denotes |
During the convalescent phase of the infection, a decline in the IgG level was observed in patients who were followed for >100 days. |
T15 |
1602-1710 |
Sentence |
denotes |
Despite that decline, 92.3 % of the patient cohort remained IgG positive 3-6 months following symptom onset. |
T16 |
1711-1723 |
Sentence |
denotes |
CONCLUSIONS: |
T17 |
1724-1907 |
Sentence |
denotes |
This study demonstrates the Abbott IgM assay against SARS-CoV-2 is detected slightly earlier compared to IgG, with both tests exhibiting excellent overall sensitivity and specificity. |
T18 |
1908-2064 |
Sentence |
denotes |
In symptomatic patients who test negative by PCR for a SARS-CoV-2 infection, assessing IgM and IgG antibodies can aid in supporting a diagnosis of COVID-19. |